Document is current

Article History

Received: 10 February 2025

Accepted: 16 June 2025

First Online: 31 July 2025

Declarations

:

: The Ethics Committee of Capital Region of Denmark approval number: H-18010607.

: Sponsor, steering group, and investigators have no conflicts of interest with funding bodies. Funding bodies have not been involved in any part of the design, conduct, analysis, interpretation, and reporting of this trial. The Steering Committee had the overall responsibility for the planning, conducting, and reporting of the trial. Decisions relevant for day-to-day management were handled by the Executive Committee.The following authors declare no known competing interests: AKP, NNL, CLT, NLJ, CU, SHC, VU, ACM, MR, LP, HKI, GSH, EDT, LKHC, JE, CG, PHT, KH, FV, WB, PJ, JRMJ, SV, MHO, JH, KJP. Hartwig R. Siebner has received honoraria as speaker from Sanofi Genzyme, Denmark and Novartis, Denmark, as consultant from Sanofi Genzyme, Denmark, and Lundbeck AS, Denmark, and as editor-in-chief (Neuroimage Clinical) and senior editor (NeuroImage) from Elsevier Publishers, Amsterdam, The Netherlands. He has received royalties as book editor from Springer Publishers, Stuttgart, Germany, Gyldendal Publishers, Copenhagen, Denmark, and Oxford University Press, Oxford, UK.